GL1X · GenesisL1 explorer

Research workbench

Antibodies specifically targeting a locally misfolded region of tumor associated EGFR

Analyse Antibodies specifically targeting a locally misfolded region of tumor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3G5Y
Type
protein
Length
439 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
175 light chain; 175 heavy chain; EGFR peptide
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 3 distinct chains · 5% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A175 light chainprotein2135% helix, 52% strand—
B175 heavy chainprotein2106% helix, 53% strand—
EEGFR peptideprotein160% helix, 38% strand—

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14980.580.7360empty

Interfaces

3 interfaces between chains.

  • A–B · 1894 Ų buried · 13 hydrogen bonds · protein-protein
  • B–E · 387 Ų buried · 9 hydrogen bonds · protein-protein
  • A–E · 323 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 3G5Y · Antibodies Specifically Targeting a Locally Misfolded Region of Tumor Associated EGFR · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.